Quest Laboratories Ltd (QUESTLAB) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: QUESTLAB | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

Quest Laboratories Ltd (QUESTLAB) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: QUESTLAB | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Quest Laboratories

Based on:

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Quest Laboratories stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
10.27
Market Cap:
139.3 Cr.
52-wk low:
0
52-wk high:
0

Is Quest Laboratories Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Quest Laboratories: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Quest Laboratories Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 12.3%55%46.5%57.5%26.9%-
Value Creation
Index
-0.12.92.33.10.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 30.459.561.682.6104104
Sales YoY Gr.-95.9%3.6%33.9%25.9%-
Adj EPS 0.63.84.68.58.38.3
YoY Gr.-547.5%20.4%83.9%-2.1%-
BVPS (₹) 5.59.3142449.954.9
Adj Net
Profit
0.64.1510.113.614
Cash Flow from Ops. 1.13.53.93-23.3-
Debt/CF from Ops. 2.90.91.11.7-1.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA20.5%25.9%
Adj EPS NANA29.4%-2.1%
BVPSNANA75.3%108.1%
Share Price - - - -24.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
10.851.939.546.224.615.8
Op. Profit
Mgn %
4.710.912.718.915.423
Net Profit
Mgn %
2.16.9812.213.113.1
Debt to
Equity
0.50.30.30.20.40
Working Cap
Days
0116186190177203
Cash Conv.
Cycle
0131031107129

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Quest Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 8.3 -
TTM Sales (₹ Cr.) 104 -
BVPS (₹.) 54.9 -
Reserves (₹ Cr.) 74 -
P/BV 1.55 -
PE 10.27 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 139
Equity (₹ Cr.) 16.4
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Quest Laboratories:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Quest Laboratories - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Quest Laboratories

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25
Sales30596283104
Operating Expenses 2953546788
Manufacturing Costs11111
Material Costs2444425279
Employee Cost 33344
Other Costs 14893
Operating Profit 1681616
Operating Profit Margin (%) 4.7%10.9%12.7%18.9%15.4%
Other Income 00004
Interest 00111
Depreciation 00111
Exceptional Items 00000
Profit Before Tax 1671419
Tax 02245
Profit After Tax 1451014
PAT Margin (%) 2.2%6.9%8.2%12.2%13.0%
Adjusted EPS (₹)0.63.84.78.58.3
Dividend Payout Ratio (%)0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 610152982
Share Capital 1111216
Reserves 59141765
Minority Interest00000
Debt334530
Long Term Debt11211
Short Term Debt222428
Trade Payables81725216
Others Liabilities 25364
Total Liabilities 18354761122

Fixed Assets

Gross Block810131416
Accumulated Depreciation23344
Net Fixed Assets 67101012
CWIP 00000
Investments 000752
Inventories11111621
Trade Receivables922202430
Cash Equivalents 02000
Others Assets 23636
Total Assets 18354761122

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 1343-23
PBT 1671419
Adjustment 1111-3
Changes in Working Capital -0-3-2-8-35
Tax Paid -0-0-2-4-4
Cash Flow From Investing Activity -1-2-4-5-44
Capex -1-2-3-1-3
Net Investments 000-4-44
Others 00-103
Cash Flow From Financing Activity 0-00267
Net Proceeds from Shares 000343
Net Proceeds from Borrowing 001-10
Interest Paid -0-0-1-1-1
Dividend Paid 00000
Others 0-00025
Net Cash Flow -0100-0

Finance Ratio

PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)11.1251.6940.2146.1324.56
ROCE (%)12.285546.5457.5126.87
Asset Turnover Ratio1.652.241.511.541.14
PAT to CFO Conversion(x)10.750.80.3-1.64
Working Capital Days
Receivable Days110961249896
Inventory Days106366066
Payable Days11910318215861

Quest Laboratories Ltd Stock News

Quest Laboratories Ltd FAQs

The current trading price of Quest Laboratories on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Quest Laboratories stood at ₹139.3.
The latest P/E ratio of Quest Laboratories as of 31-Dec-1969 is 10.27.
The latest P/B ratio of Quest Laboratories as of 31-Dec-1969 is 1.55.
The 52-week high of Quest Laboratories is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Quest Laboratories is ₹104.0 ( Cr.) .

About Quest Laboratories Ltd

Quest Laboratories Limited was originally incorporated under the name ‘Quest Laboratories Private Limited’ under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated June 01, 1998, issued by the Registrar of Companies Madhya Pradesh, Gwalior. Subsequently, the status of the Company was changed to public limited and the name of Company was changed to ‘Quest Laboratories Limited’ vide Special Resolution passed by the Shareholders at the Extra Ordinary General Meeting of its Company held on January 11, 2024. The fresh certificate of incorporation consequent to conversion was issued on January 23, 2024, by Assistant Registrar of Companies/ Deputy Registrar of Companies/ Registrar of Companies, Centralised Processing Centre. 

Quest Laboratories is engaged in the business of manufacturing of pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. These formulations fall under the trademark ‘Quest Laboratories’. The company produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC). These products are available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. This comprehensive approach allows the Company to address a wide range of medical needs and preferences among patients. 

The Company holds World Health Orgabnization (WHO) Schedule M GMP, and GLP certifications, adhering to the stringent guidelines set by the World Health Organization. Its commitment to quality is further demonstrated by its ISO 9001:2015 certification and ISO/IEC 17025:2017 accreditation. With manufacturing under one roof, the company maintains stringent quality control standards throughout the entire manufacturing process. By doing so, it ensures that its products meet the relevant quality standards before they reach the market. 

The company also possesses Good Laboratory Practice (GLP) certificate issued by Food & Drug Administration, Bhopal, Madhya Pradesh, indicating its commitment to maintaining high standards of quality and compliance in laboratory operations, particularly within the pharmaceutical sector. Its in-house laboratory is equipped with various equipment such as HPLC (High-Performance Liquid Chromatography), GC (Gas Chromatography), FTIR (Fourier Transform Infrared Spectroscopy), UV (Ultraviolet-Visible Spectroscopy), Dissolution apparatus, and other advanced instruments. This comprehensive suite of tools enables it to conduct a wide array of tests and analyses efficiently and accurately. 

Business area of the company

The company is primarily engaged in the manufacturing of pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. The company also produces variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC).

Products of the company

  • Tablets
  • Dry syrup & suspension
  • Ointment
  • Oral Rehydration Salt (ORS)

History and milestones 

  • 1998: Incorporation of the Company as Private Limited Company 
  • 1998: Good Manufacturing Practices Certificate. 
  • 1998: Good Laboratory Practices Certificate.
  • 2022: ISO/IEC 17025:2017 for General Requirements for the Competence of Testing & Calibration Laboratories. 
  • 2023: ISO 9001:2015 in accordance with the requirements Quality Management System standard. 
  • 2023: Zed Bronze under MSME Sustainable (ZED) Certification. 
  • 2024: Conversion of Company from Private Limited to Public Limited Company.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×